Cargando…

CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection

BACKGROUND: The gene for chromodomain helicase/ATPase DNA binding protein 1-like (CHD1L) was recently identified as a target oncogene within the 1q21 amplicon, which occurs in 46% to 86% of primary hepatocellular carcinoma (HCC) cases. However, the prognostic significance of CHD1L in HCC remains unc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyeon, Jiyeon, Ahn, Soomin, Park, Cheol-Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and The Korean Society for Cytopathology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589617/ https://www.ncbi.nlm.nih.gov/pubmed/23482400 http://dx.doi.org/10.4132/KoreanJPathol.2013.47.1.9

Ejemplares similares

Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy
por: Ahn, Soomin, et al.
Publicado: (2013)

Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma
por: Hyeon, Jiyeon, et al.
Publicado: (2013)

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
por: Hwang, Hye Won, et al.
Publicado: (2015)

The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
por: Ha, Sang Yun, et al.
Publicado: (2016)

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma
por: Huang, Wei-Ju, et al.
Publicado: (2015)

The single-nucleotide polymorphisms in CHD5 affect the prognosis of patients with hepatocellular carcinoma
por: Zhu, Xiao, et al.
Publicado: (2017)

High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Lee, Boin, et al.
Publicado: (2014)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma
por: Yang, Hua, et al.
Publicado: (2012)

Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma
por: Liu, Ze-Han, et al.
Publicado: (2017)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jung, Hae Il, et al.
Publicado: (2017)

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
por: Shin, Jin Ho, et al.
Publicado: (2015)

Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection
por: Mao, Shuqi, et al.
Publicado: (2022)

The Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma
por: Jang, Se Young, et al.
Publicado: (2016)

TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection
por: Wang, Cheng-Hao, et al.
Publicado: (2015)

High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2020)

CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3
por: Zhang, Xiaofeng, et al.
Publicado: (2021)

Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child–Pugh A
por: Zhou, Jing, et al.
Publicado: (2022)

Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma
por: Xie, Cheng-Rong, et al.
Publicado: (2015)

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection
por: Ji, Gu-Wei, et al.
Publicado: (2021)

Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
por: Kim, Jongmin, et al.
Publicado: (2009)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection
por: Sun, Jialei, et al.
Publicado: (2019)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma
por: Bang, Heejin, et al.
Publicado: (2015)

Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area
por: Yu, Jeong Il, et al.
Publicado: (2017)

CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma
por: Li, Shimiao, et al.
Publicado: (2019)

CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma
por: Li, Shimiao, et al.
Publicado: (2019)

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
por: Wang, W, et al.
Publicado: (2004)

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients
por: Ha, Sang Yun, et al.
Publicado: (2015)

Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma
por: Wei, Cheng-Yi, et al.
Publicado: (2020)

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection [Corrigendum]
Publicado: (2021)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
por: Perng, Daw-Shyong, et al.
Publicado: (2021)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma
por: Yu, Lei, et al.
Publicado: (2015)

Surgical Resection of Ruptured Fibrolamellar Hepatocellular Carcinoma
por: Minutolo, Vincenzo, et al.
Publicado: (2013)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma
por: Dai, Xiaomeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bjd5req0vabn8a9ri2crlpj9q1